179 related articles for article (PubMed ID: 30028955)
1. Molecular imaging in dementia: Past, present, and future.
Laforce R; Soucy JP; Sellami L; Dallaire-Théroux C; Brunet F; Bergeron D; Miller BL; Ossenkoppele R
Alzheimers Dement; 2018 Nov; 14(11):1522-1552. PubMed ID: 30028955
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.
Matsuda H; Shigemoto Y; Sato N
Jpn J Radiol; 2019 Nov; 37(11):735-749. PubMed ID: 31493197
[TBL] [Abstract][Full Text] [Related]
3. [Amyloid positron-emission-tomography with [
Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
[TBL] [Abstract][Full Text] [Related]
4. Molecular neuroimaging in degenerative dementias.
Jiménez Bonilla JF; Carril Carril JM
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):301-9. PubMed ID: 23933381
[TBL] [Abstract][Full Text] [Related]
5. [Current and future prospects of nuclear medicine in dementia].
Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
[TBL] [Abstract][Full Text] [Related]
6. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
9. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
10. Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.
Eisenmenger LB; Huo EJ; Hoffman JM; Minoshima S; Matesan MC; Lewis DH; Lopresti BJ; Mathis CA; Okonkwo DO; Mountz JM
Semin Nucl Med; 2016 Jan; 46(1):57-87. PubMed ID: 26687858
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.
Arbizu J; García-Ribas G; Carrió I; Garrastachu P; Martínez-Lage P; Molinuevo JL
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):303-13. PubMed ID: 26099942
[TBL] [Abstract][Full Text] [Related]
13. PET radiotracers for molecular imaging in dementia.
Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
[TBL] [Abstract][Full Text] [Related]
14. New PET markers for the diagnosis of dementia.
Payoux P; Salabert AS
Curr Opin Neurol; 2017 Dec; 30(6):608-616. PubMed ID: 28906268
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic impact of [
Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-plaque imaging in early and differential diagnosis of dementia.
Drzezga A
Ann Nucl Med; 2010 Feb; 24(2):55-66. PubMed ID: 20082230
[TBL] [Abstract][Full Text] [Related]
17. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
Wren MC; Lashley T; Årstad E; Sander K
Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
Del Sole A; Malaspina S; Magenta Biasina A
Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
[TBL] [Abstract][Full Text] [Related]
19. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
[TBL] [Abstract][Full Text] [Related]
20. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
Silverman DH
J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
